A Feasibility Randomized Control Trial to Investigate the in Silico Optimization of Insulin Treatments
The primary objective of this study is to assess the performance of an in silico designed alternative protocol for control of stress hyperglycemia of inpatients treated for Coronary Artery Bypass Graft (CABG) or valve replacement surgery in the University of Virginia cardiothoracic ICU.
• Patients admitted for CABG and/or open heart valve surgery
• Must have a 0.05 initial multiplier setting for the Glucommander based on the manufacturers recommendations
• Age of 40-75, inclusive